| CRIS Sector / Industry Membership |
|---|
| Sector: | Healthcare |
|---|
| Industry: | Biotechnology |
|---|
|
| Intraday Performance Summary |
|---|
| Top Biotechnology Companies by Market Cap |
|---|
| CRIS vs. Industry Leaders |
|---|
| Statistic | Industry Leader | CRIS | CRIS Rank |
|---|
| Market Capitalization | RHHBYN.MX | 2.66T | 297.99M | 122
/ 436 | | P/E Ratio (ttm) | GNS.L | 2,296.53 | N/A | N/A | | PEG Ratio (ttm, 5 yr expected) | MSB.AX | 11.35 | N/A | N/A | | Revenue Growth (Qtrly YoY) | PA8.DE | 997.70% | -91.60% | 232
/ 436 | | EPS Growth (Qtrly YoY) | BSTC | 72.70% | N/A | N/A | | Long-Term Growth Rate (5 yr) | INCY | 93.70% | N/A | N/A | | Return on Equity (ttm) | PA8.DE | 211.92% | -60.65% | 158
/ 436 | | Long-Term Debt/Equity (mrq) | | | 99.633 | N/A | | Dividend Yield (annual) | NPC.TO | 17.40% | N/A | N/A |
|
Currency in USD. |
|
|